Replies to post #592226 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

No, that's not what that means at all. 1) revenue doubled over the course of the year, so that for this first quarter of 2023 only, that's the number, 2) it was commercially only approved as of March 20th, 2023; 3) This quarterly report is only up to March 31, 2023.

Further, the factors I mentioned before would be reason to expect a gradual scale up anyway. It's not like 2,000 patients with doctors familiar with this treatment and interested all suddenly have their surgery in 1 month and also have the funds to access the treatment immediately. That is going to scale up gradually especially because of the out of pocket aspect and it's not yet approved in the UK or covered by NIH, but is basically still outside of the system and a special for patients whose doctors are in the know and patients that have the money immediately available.

[Jarheef]

How you gonna downplay revenue increases by 100% bruh(full transparency I haven’t read the filing just going off your post here) That’s one of those it’s a good thing no matter how you slice it kinda things isn’t it?

[Maverick0408]

No point responding to paid pumpers. It’s so obvious and they will never admit it. Just like they will never admit that LG lied again last month that they are backlogged.

Makes you question their statements around combo discussions in the 10Q. Are they lying/exaggerating there as well just as months turned to years around TLD release?